File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Article: Kinase Inhibitors for the Treatment of Rheumatoid Arthritis
| Title | Kinase Inhibitors for the Treatment of Rheumatoid Arthritis |
|---|---|
| Authors | |
| Keywords | Janus kinase Mitogen-activated protein kinase Protein kinase inhibitor Rheumatoid arthritis Spleen tyrosine kinase |
| Issue Date | 2012 |
| Publisher | The Hong Kong Society of Rheumatology. The Journal's web site is located at http://www.rheumatology.org.hk/main.php?id=27&lang=eng |
| Citation | Hong Kong Bulletin on Rheumatic Diseases, 2012, v. 12 n. 2, p. 43-49 How to Cite? |
| Abstract | The use of biologics has been a major advance in the treatment of rheumatoid arthritis over the last decade. However, their need for a parenteral route of administration has made them less desirable for some patients. Efforts have been channelled into the development of oral tyrosine kinase inhibitors, and their results have been promising. This article will provide an overall review of three main tyrosine kinase inhibitors which have been studied for patients with rheumatoid arthritis. |
| Persistent Identifier | http://hdl.handle.net/10722/189257 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Tsang, HHL | en_US |
| dc.contributor.author | Chung, HY | en_US |
| dc.contributor.author | Mok, MY | en_US |
| dc.contributor.author | Lau, CS | en_US |
| dc.date.accessioned | 2013-09-17T14:31:00Z | - |
| dc.date.available | 2013-09-17T14:31:00Z | - |
| dc.date.issued | 2012 | en_US |
| dc.identifier.citation | Hong Kong Bulletin on Rheumatic Diseases, 2012, v. 12 n. 2, p. 43-49 | en_US |
| dc.identifier.uri | http://hdl.handle.net/10722/189257 | - |
| dc.description.abstract | The use of biologics has been a major advance in the treatment of rheumatoid arthritis over the last decade. However, their need for a parenteral route of administration has made them less desirable for some patients. Efforts have been channelled into the development of oral tyrosine kinase inhibitors, and their results have been promising. This article will provide an overall review of three main tyrosine kinase inhibitors which have been studied for patients with rheumatoid arthritis. | - |
| dc.language | eng | en_US |
| dc.publisher | The Hong Kong Society of Rheumatology. The Journal's web site is located at http://www.rheumatology.org.hk/main.php?id=27&lang=eng | - |
| dc.relation.ispartof | Hong Kong Bulletin on Rheumatic Diseases | en_US |
| dc.subject | Janus kinase | - |
| dc.subject | Mitogen-activated protein kinase | - |
| dc.subject | Protein kinase inhibitor | - |
| dc.subject | Rheumatoid arthritis | - |
| dc.subject | Spleen tyrosine kinase | - |
| dc.title | Kinase Inhibitors for the Treatment of Rheumatoid Arthritis | en_US |
| dc.type | Article | en_US |
| dc.identifier.email | Mok, MY: temy@hkucc.hku.hk | en_US |
| dc.identifier.email | Lau, CS: cslau@hku.hk | en_US |
| dc.identifier.authority | Mok, TMY=rp00490 | en_US |
| dc.identifier.authority | Lau, WCS=rp01348 | en_US |
| dc.identifier.hkuros | 223173 | en_US |
| dc.identifier.hkuros | 224429 | - |
| dc.identifier.volume | 12 | en_US |
| dc.identifier.issue | 2 | - |
| dc.identifier.spage | 43 | en_US |
| dc.identifier.epage | 49 | en_US |
| dc.publisher.place | Hong Kong | - |